These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 19781375)
1. Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice. Cao J; Liu FX; Yu MX Chin Med J (Engl); 2009 Aug; 122(16):1941-6. PubMed ID: 19781375 [TBL] [Abstract][Full Text] [Related]
2. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472 [TBL] [Abstract][Full Text] [Related]
3. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation. Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438 [TBL] [Abstract][Full Text] [Related]
4. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers. Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813 [TBL] [Abstract][Full Text] [Related]
5. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Liang SC; Latchman YE; Buhlmann JE; Tomczak MF; Horwitz BH; Freeman GJ; Sharpe AH Eur J Immunol; 2003 Oct; 33(10):2706-16. PubMed ID: 14515254 [TBL] [Abstract][Full Text] [Related]
6. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Waeckerle-Men Y; Starke A; Wüthrich RP Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272 [TBL] [Abstract][Full Text] [Related]
7. Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma. He L; Zhang G; He Y; Zhu H; Zhang H; Feng Z Anticancer Res; 2005; 25(5):3309-13. PubMed ID: 16101143 [TBL] [Abstract][Full Text] [Related]
8. PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis. Ding H; Wu X; Gao W Clin Immunol; 2005 May; 115(2):184-91. PubMed ID: 15885642 [TBL] [Abstract][Full Text] [Related]
9. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257 [TBL] [Abstract][Full Text] [Related]
10. Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. Mataki N; Kikuchi K; Kawai T; Higashiyama M; Okada Y; Kurihara C; Hokari R; Kawaguchi A; Nagao S; Kondo T; Itoh K; Miyakawa H; Miura S Am J Gastroenterol; 2007 Feb; 102(2):302-12. PubMed ID: 17311651 [TBL] [Abstract][Full Text] [Related]
11. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209 [TBL] [Abstract][Full Text] [Related]
12. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847 [TBL] [Abstract][Full Text] [Related]
13. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. English K; Barry FP; Field-Corbett CP; Mahon BP Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101 [TBL] [Abstract][Full Text] [Related]
14. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Terrazas LI; Montero D; Terrazas CA; Reyes JL; Rodríguez-Sosa M Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211 [TBL] [Abstract][Full Text] [Related]
15. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527 [TBL] [Abstract][Full Text] [Related]